News
-
-
-
COMMUNIQUÉ DE PRESSE
Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024
Moderna, Inc. announces its fifth annual Investor Event focusing on vaccines and business updates on March 27, 2024. Presentation at 9:00 a.m. ET. Live webcast available on the Moderna website -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $2.8 billion with a GAAP net income of $217 million. Expects regulatory approvals for RSV vaccine and forecasts 2024 product sales of $4 billion -
COMMUNIQUÉ DE PRESSE
Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Moderna, Inc.'s CEO Stéphane Bancel elected to National Academy of Engineering for distinguished contributions to engineering and manufacturing of pharmaceutical products, including COVID-19 vaccine. Company has 45 mRNA therapeutic and vaccine programs in pipeline
